Kimelman & Baird LLC Purchases Shares of 10,300 Colgate-Palmolive (NYSE:CL)

Kimelman & Baird LLC bought a new stake in shares of Colgate-Palmolive (NYSE:CLFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 10,300 shares of the company’s stock, valued at approximately $1,000,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CL. Gryphon Financial Partners LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $225,000. Focus Financial Network Inc. ADV purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $394,000. Dorsey & Whitney Trust CO LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $218,000. Partners Capital Investment Group LLP bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $218,000. Finally, California State Teachers Retirement System lifted its holdings in shares of Colgate-Palmolive by 1.2% in the fourth quarter. California State Teachers Retirement System now owns 1,291,539 shares of the company’s stock worth $102,949,000 after buying an additional 15,620 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Up 0.6 %

Shares of Colgate-Palmolive stock opened at $103.66 on Monday. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The stock has a market cap of $85.05 billion, a PE ratio of 32.80, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40. The firm has a fifty day moving average price of $103.25 and a 200 day moving average price of $96.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target for the company. Barclays lifted their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. UBS Group increased their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $104.74.

Get Our Latest Stock Report on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.